Indefinite Delivery Contract 36C24E26D0009
- Not listed
- Infinity Biologix LLC, operating as the Sampled Division and headquartered in Piscataway, New Jersey, holds a single-award Indefinite Delivery Contract valued at $37 million with a civilian federal agency for genomic analysis services. The contract, awarded September 30, 2020, with an ultimate completion date of March 1, 2026, encompasses comprehensive genomic research support services including high-throughput custom genotyping, DNA methylation analysis, DNA extraction, genotyping,...
- Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, has been awarded a Blanket Purchase Agreement (BPA) by Veterans Integrated Service Network 16 (VISN 16), a civilian component of the Department of Veterans Affairs, with a ceiling value of $231,165.00 and a period of performance extending through September 30, 2030. The prime contractor will deliver Illumina reagents, consumables, and support plans to enable genomic sequencing and...
- This Indefinite Delivery Contract was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing and analysis technologies. The contract has a ceiling value of $1,297,062 and a period of performance through August 13, 2029. Under this IDC, the VA's Veterans Integrated Service Network 8 (VISN 8) has issued two firm-fixed price delivery orders to date, valued at $254,423.70 and $249,435.00, respectively. These orders are for the procurement of...
- Cepheid has been awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the Department of Veterans Affairs, valued at $4.5 million with a period of performance extending through February 28, 2031. The contract, awarded on March 1, 2026, utilizes no set-aside provisions and establishes a firm fixed-price procurement framework for the GeneXpert Infinity 80-80 instrument lease with associated reagents and supplies. This...
- The Department of Veterans Affairs Veterans Integrated Service Network 2 awarded a single-award Indefinite Delivery Contract to New York Genome Center, Inc. (NYGC) on December 1, 2022, with a ceiling value of $356,920 and ultimate completion date of May 31, 2026. This civilian contract vehicle supports next-generation sequencing for ongoing research studies conducted by the Veterans Health Administration. NYGC, a non-profit academic research institution specializing in advanced genomic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 1, awarded a single-award Indefinite Delivery Contract valued at $35.2 million to Tempus AI, Inc. (doing business as Tempus Labs Inc.) on March 2, 2026, with an ultimate completion date of September 1, 2031. This contract procures TASSO+ assay testing services in support of the Million Veteran Program (MVP), a large-scale genomic research initiative designed to advance precision medicine and personalized cancer treatment...
- This Indefinite Delivery Contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $1,000,000.00 and a period of performance from January 1, 2024 to March 31, 2026. The contract is for the provision of CEPHEID GENEXPERT INFINITY MOLECULAR REAGENTS to support clinical testing programs for veterans. Two task orders have been issued under this IDC,...
- The federal contract IDV award is a single-award Indefinite Delivery Contract awarded to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The contract has a ceiling value of $500,000 and an ultimate completion date of September 21, 2029, with an award date of September 22, 2025. The contract is funded by the Department of Veterans Affairs (VA) and supports specialized DNA and medical study services focused on genetic factors...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a single-award Blanket Purchase Agreement (BPA) to Illumina, Inc. for the procurement of Illumina reagents, accessories, and sequencing systems. The BPA is valued up to $8,404.98 and has a period of performance through May 12, 2029. The VA is using simplified acquisition procedures under FAR 13.106-1(b)(1)(i) to sole-source this requirement to Illumina as the incumbent and likely sole available source due to the...
- The U.S. Department of Agriculture's Agricultural Research Service awarded a single-award Indefinite Delivery Contract valued at $158,699.83 to Infinity Biologix LLC (doing business as Sampled Division) on September 18, 2023, for next-generation sequencing services and bioinformatic analyses. The contract was set aside for total small business and maintains a ceiling completion date of September 17, 2025. Infinity Biologix, a for-profit limited liability company based in Piscataway, New...
This Indefinite Delivery Contract was awarded to Infinity Biologix LLC (UEI: NPUACRBK7TV9) on March 2, 2026, by the Department of Veterans Affairs, Veterans Integrated Service Network 1, with a contract ceiling of $27.1 million and a completion date of September 1, 2031. The contract is structured as a single-award, non-set-aside indefinite delivery vehicle supporting the Minimally Invasive Validation (MVP) Program through provision of long-read sequencing services. As a civilian federal agency procurement, this contract leverages Infinity Biologix's established expertise in advanced genomic analysis and next-generation sequencing technologies to support the Department of Veterans Affairs' research initiatives. Infinity Biologix, a for-profit limited liability company based in Piscataway, New Jersey, brings substantial capacity to this engagement through its proven track record delivering high-complexity genomic research services to multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and National Cancer Institute. The contractor's service portfolio encompasses DNA sequencing, genotyping, genomic characterization, and biospecimen processing—capabilities directly applicable to the Department of Veterans Affairs' long-read sequencing requirements under the MVP Program. The five-year contract period through September 2031 establishes a framework for the Department of Veterans Affairs to issue task orders for long-read sequencing services as research needs arise within the MVP Program, with the $27.1 million ceiling establishing the maximum obligation for all delivery orders throughout the contract's performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/26/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--Genotyping, Long-Read Sequencing, and Annotation | 36C24E25R0034 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 | Award Notice 1/1 | 2/27/26, 6:43 AM |